Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy

We evaluated the efficacy and safety of loading phase treatment with intravitreal brolucizumab for neovascular age-related macular degeneration (nAMD) with type 1 choroidal neovascularization (CNV). We analyzed consecutive 42 eyes of 40 patients with treatment-naïve nAMD associated with type 1 CNV....

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hidetaka, Hoshino, Junki, Mukai, Ryo, Nakamura, Kosuke, Akiyama, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990919/
https://www.ncbi.nlm.nih.gov/pubmed/33762600
http://dx.doi.org/10.1038/s41598-021-86014-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990919/
https://www.ncbi.nlm.nih.gov/pubmed/33762600
http://dx.doi.org/10.1038/s41598-021-86014-7

Ejemplares similares